We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$77.6B
AUM Growth
+$5.19B
Cap. Flow
+$4.38B
Cap. Flow %
5.65%
Top 10 Hldgs %
15.11%
Holding
3,002
New
251
Increased
1,435
Reduced
1,132
Closed
141

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$523M
2
MRK icon
Merck
MRK
+$243M
3
TSLA icon
Tesla
TSLA
+$188M
4
ADBE icon
Adobe
ADBE
+$159M
5
INFY icon
Infosys
INFY
+$150M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$143M
2
CI icon
Cigna
CI
+$133M
3
DAL icon
Delta Air Lines
DAL
+$121M
4
DIS icon
Walt Disney
DIS
+$120M
5
CSCO icon
Cisco
CSCO
+$113M

Sector Composition

Rank Sector Weight
1 Technology 24.8%
2 Financials 15.9%
3 Healthcare 13.33%
4 Consumer Discretionary 11.85%
5 Industrials 11.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IIPR icon
2901
Innovative Industrial Properties
IIPR
$1.66B
-4,138
Closed -$557K
IMTM icon
2902
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.27B
-10,384
Closed -$419K
IMVT icon
2903
Immunovant
IMVT
$8.24B
-10,082
Closed -$287K
INBX icon
2904
Inhibrx
INBX
$1.37B
-13,012
Closed -$204K
IPI icon
2905
Intrepid Potash
IPI
$508M
-30,466
Closed -$731K
KALV
2906
DELISTED
KalVista Pharmaceuticals
KALV
-12,354
Closed -$143K
KB icon
2907
KB Financial Group
KB
$42.4B
-8,874
Closed -$563K
KOD icon
2908
Kodiak Sciences
KOD
$2.72B
-35,537
Closed -$92.8K
KPTI icon
2909
Karyopharm Therapeutics
KPTI
$44.4M
-815
Closed -$10.1K
LRMR icon
2910
Larimar Therapeutics
LRMR
$417M
-15,712
Closed -$103K
LXU icon
2911
LSB Industries
LXU
$726M
-25,180
Closed -$202K
MARA icon
2912
Marathon Digital Holdings
MARA
$3.69B
-15,841
Closed -$257K
MASS icon
2913
908 Devices
MASS
$361M
-152,053
Closed -$528K
MFDX icon
2914
PIMCO RAFI Multi-Factor International Equity ETF
MFDX
$468M
-6,661
Closed -$217K
MGPI icon
2915
MGP Ingredients
MGPI
$381M
-5,570
Closed -$464K
MNTK icon
2916
Montauk Renewables
MNTK
$243M
-10,851
Closed -$56.5K
MRNA icon
2917
Moderna
MRNA
$23.9B
-3,010
Closed -$201K
MSGE icon
2918
Madison Square Garden
MSGE
$3.69B
-5,317
Closed -$225K
MX icon
2919
Magnachip Semiconductor
MX
$134M
-38,300
Closed -$179K
NAMS icon
2920
NewAmsterdam Pharma
NAMS
$3.34B
-15,936
Closed -$265K
NGG icon
2921
National Grid
NGG
$79.9B
-3,293
Closed -$216K
NIO icon
2922
NIO
NIO
$12.1B
-11,625
Closed -$77.7K
OCGN icon
2923
Ocugen
OCGN
$444M
-36,341
Closed -$36.1K
ORC
2924
Orchid Island Capital
ORC
$1.3B
-10,573
Closed -$86.9K
PANL icon
2925
Pangaea Logistics
PANL
$479M
-85,330
Closed -$617K

Similar funds

AQR Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, AQR Capital Management held 3,002 positions worth $77.6B, up 7.2% from $72.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

AQR Capital Management deployed $4.38B of net new capital in Q4 2024, opening 251 new positions and adding to 1,435 existing holdings. Its largest new stake was iShares Russell 2000 Value ETF: 98,982 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $143M trimmed.

  • AQR Capital Management's largest Q4 2024 buy was iShares Russell 2000 Value ETF: 98,982 shares worth $16.2M.
  • AQR Capital Management added most to Apple in Q4 2024, an estimated $523M increase.
  • AQR Capital Management's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $143M.
  • AQR Capital Management fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $5.41M.
  • AQR Capital Management's ten largest holdings make up 15% of its $77.6B portfolio in Q4 2024.
  • AQR Capital Management opened 251 new positions and closed 141 in Q4 2024.
  • AQR Capital Management's portfolio value rose 7.2% quarter-over-quarter to $77.6B.

Based on AQR Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.